Avantor, Inc. is a life science tools company that engages in providing mission-critical products and services to the life sciences and advanced technology industries. The company is headquartered in Radnor, Pennsylvania and currently employs 13,500 full-time employees. The company went IPO on 2019-05-17. The Company’s segments include Laboratory Solutions and Bioscience Production. Within its segments, it sells materials and consumables, equipment and instrumentation and services and specialty procurement to customers in the biopharma and healthcare, education and government and advanced technologies and applied materials industries. Materials and consumables include ultra-high purity chemicals and reagents, lab products and supplies, highly specialized formulated silicone materials, customized excipients, and others. Equipment and instrumentation include filtration systems, virus inactivation systems, incubators, analytical instruments, and others. Services and specialty procurement include onsite lab and production, equipment, procurement and sourcing and biopharmaceutical material scale-up and development services.
Follow-Up Questions
¿Cuál es el ratio P/E de Avantor Inc (AVTR)?
El ratio P/E de Avantor Inc es 13.2946
¿Quién es el CEO de Avantor Inc?
Mr. Emmanuel Ligner es el President de Avantor Inc, se unió a la empresa desde 2025.
¿Qué tal es el rendimiento del precio de la acción AVTR?
El precio actual de AVTR es de $11.58, ha decreased un 0% en el último día de negociación.
¿Cuáles son los temas de negocio principales o las industrias de Avantor Inc?
Avantor Inc pertenece a la industria Life Sciences Tools & Services y el sector es Health Care
¿Cuál es la capitalización bursátil de Avantor Inc?
La capitalización bursátil actual de Avantor Inc es $7.8B
¿Es Avantor Inc una compra, una venta o una posición de mantener?
Según los analistas de Wall Street, 20 analistas han realizado calificaciones de análisis para Avantor Inc, incluyendo 4 fuerte compra, 10 compra, 15 mantener, 0 venta, y 4 fuerte venta
